|
|
Volumn 509, Issue 7502, 2014, Pages
|
|
Biology: Three known unknowns
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMATINIB;
ANTINEOPLASTIC AGENT;
DNA;
BREAST CANCER;
CANCER CELL LINE;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER GENETICS;
CANCER GROWTH;
CANCER RESEARCH;
CHRONIC MYELOID LEUKEMIA;
DRUG INDUSTRY;
GENE EXPRESSION;
GENE SEQUENCE;
GENETIC VARIABILITY;
HUMAN;
METASTASIS;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
SMOKING CESSATION;
TUMOR INVASION;
TUMOR MICROENVIRONMENT;
ARTICLE;
BIOLOGY;
CANCER BIOLOGY;
CANCER CELL;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER RESISTANCE;
CANCER SURGERY;
CANCER THERAPY;
DNA REPAIR;
DRUG DESIGN;
GENE MUTATION;
GENE TARGETING;
IMMUNE SYSTEM;
IN VITRO STUDY;
NEOPLASM;
PERSONALIZED MEDICINE;
TUMOR CELL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BENZAMIDES;
BIOLOGICAL EVOLUTION;
DRUG RESISTANCE, NEOPLASM;
GENES, TUMOR SUPPRESSOR;
HUMANS;
IMMUNITY;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
NEOPLASM METASTASIS;
NEOPLASMS;
PIPERAZINES;
PYRIMIDINES;
TUMOR MICROENVIRONMENT;
CANCER;
DRUG;
DRUG RESISTANCE;
GENE;
|
|
EID: 84901594818
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/509S69a Document Type: Note |
|
Times cited : (32)
|
|
References (0)
|
